1. Home
  2. GBIO vs XOS Comparison

GBIO vs XOS Comparison

Compare GBIO & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • XOS
  • Stock Information
  • Founded
  • GBIO 2016
  • XOS 2016
  • Country
  • GBIO United States
  • XOS United States
  • Employees
  • GBIO N/A
  • XOS N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • XOS Construction/Ag Equipment/Trucks
  • Sector
  • GBIO Health Care
  • XOS Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • XOS Nasdaq
  • Market Cap
  • GBIO 29.2M
  • XOS 25.6M
  • IPO Year
  • GBIO 2020
  • XOS N/A
  • Fundamental
  • Price
  • GBIO $0.39
  • XOS $3.49
  • Analyst Decision
  • GBIO Strong Buy
  • XOS Buy
  • Analyst Count
  • GBIO 4
  • XOS 5
  • Target Price
  • GBIO $7.33
  • XOS $8.80
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • XOS 17.6K
  • Earning Date
  • GBIO 08-06-2025
  • XOS 08-12-2025
  • Dividend Yield
  • GBIO N/A
  • XOS N/A
  • EPS Growth
  • GBIO N/A
  • XOS N/A
  • EPS
  • GBIO N/A
  • XOS N/A
  • Revenue
  • GBIO $24,556,000.00
  • XOS $48,678,000.00
  • Revenue This Year
  • GBIO N/A
  • XOS $1.45
  • Revenue Next Year
  • GBIO N/A
  • XOS $27.16
  • P/E Ratio
  • GBIO N/A
  • XOS N/A
  • Revenue Growth
  • GBIO 146.47
  • XOS N/A
  • 52 Week Low
  • GBIO $0.30
  • XOS $2.73
  • 52 Week High
  • GBIO $3.65
  • XOS $9.15
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 52.02
  • XOS 66.03
  • Support Level
  • GBIO $0.32
  • XOS $3.17
  • Resistance Level
  • GBIO $0.36
  • XOS $3.50
  • Average True Range (ATR)
  • GBIO 0.03
  • XOS 0.13
  • MACD
  • GBIO 0.00
  • XOS 0.06
  • Stochastic Oscillator
  • GBIO 81.00
  • XOS 98.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About XOS Xos Inc.

Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.

Share on Social Networks: